Rubina Siddiqi

3PUBLICATIONS
45CO-AUTHORS
Cardiovascular medicine and haematology not elsewhere classifiedHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Feb 06, 2025
Brexucabtagene Autoleucel versus Allogeneic Hematopoietic Cell Transplantation in Relapsed and Refractory Mantle Cell Lymphoma.

Nora Liebers, Ariane Boumendil, Hervé Finel

|Jun 06, 2022
Three-Year Follow-Up of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma, Including High-Risk Subgroups, in the ZUMA-2 Study.

Michael Wang, Javier Munoz, Andre Goy

|May 25, 2022
Cost-effectiveness analysis of KTE-X19 CAR T therapy versus real-world standard of care in patients with relapsed/refractory mantle cell lymphoma post BTKi in England.

Svenja Petersohn, Gilles Salles, Michael Wang

Pageof 1

Frequent Collaborators

2 joint publications

Michael Wang

1 joint publications

Svenja Petersohn

1 joint publications

Gilles Salles

1 joint publications

Jim Wu